| Line Item | 2024-02-02 | Y/Y |
|---|---|---|
| Revenue | $88.42B | -13.6% |
| Cost of Revenue | $67.56B | -15.1% |
| Gross Profit | $20.87B | -8.0% |
| R&D Expense | $2.80B | +0.8% |
| SG&A Expense | $12.86B | -9.0% |
| Operating Income | $5.21B | -9.7% |
| Interest Expense | $1.50B | +22.8% |
| Pre-tax Income | $3.89B | +20.5% |
| Income Tax | $692.0M |
| Line Item | 2024-02-02 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.37B | -14.4% |
| Inventory | $3.62B | -24.2% |
| Current Assets | $35.95B | -15.1% |
| Total Assets | $82.09B | -8.4% |
| Current Liabilities | $48.49B | -6.1% |
| Long-term Debt | $25.99B | -12.1% |
| Total Liabilities | $84.40B | -8.9% |
| Line Item | 2024-02-02 | Y/Y |
|---|---|---|
| Operating Cash Flow | $8.68B | +143.4% |
| Capital Expenditures | $2.76B | -8.2% |
| Investing Cash Flow | -$2.78B | +8.0% |
| Financing Cash Flow | -$7.09B | -336.6% |
| Free Cash Flow | $5.92B | +953.4% |
| -13.8% |
| Net Income | $3.21B | +31.5% |
| Stockholders' Equity |
| -$2.40B |
| +23.0% |